|
---|
As Of | Filer | Filing¹ | For·On·As | Docs:Size | Issuer | | Filing Agent | | | | | | | | | |
---|
|
---|
6/10/21‡ Frost Phillip MD et al SC 13D/A 6/9/21 1:64K Cocrystal Pharma, Inc. Toppan Merrill/FA
Frost Gamma Investments Trust³
Steven D. Rubin³
11/19/20 Opko Health, Inc. SC 13D/A 1:146K Cocrystal Pharma, Inc.
Frost Gamma Investments Trust³
Phillip Frost, M.D.³
Steven D. Rubin³
____________ | ‡ | A non-Insider-Ownership Filing that was accepted after the SEC “closed” at 5:30:00pm ET. The legal “Filed As Of” date may be the next, or another, day. | ¹ | Filing/Form Type: -K | | SC 13D | Statement of Acquisition of Beneficial Ownership by an “Active” Investor — Schedule 13D. | | /A | Amendment to, or Amended version of, a previous Filing of this Type. | ³ | Group Member: A Registrant or non-Registrant party to this Filing made by a Group. |
|